Ghrelin and the Endocannabinoid System Ghrelin and the endocannabinoid system interact in a bidirectional fashion
[DOI] [PubMed] [Google Scholar] 271.Karfopoulou E., Anastasiou C.A., Avgeraki E., Kosmidis M.H., Yannakoulia M
#LifeSciences #Pharma #DrugDelivery #GLP1 #LEXX #BiotechInvesting Lexaria CEO on DehydraTECH and Oral GLP-1s To view or add a comment, sign in Zacks SCR Senior Life Sciences Analyst, John Vandermosten, speaks with Lexaria Bioscience (NASDAQ: LEXX) CEO Rich Christopher about the companys DehydraTECH platform and its potential to transform GLP-1 drug delivery
BOTTOM LINE In this large Department of Veterans Affairs study, GLP-1 medications were associated with modestly lower risk of both new substance use disorder diagnoses and serious substance-related problems among those who already had a substance use disorder
Microbiome 5:153
The assessment of the redox status in relation to the progression of obesity-related comorbidities such as metabolic syndrome, diabetes, and cardiovascular disease (CVD) in cohort studies on adolescents could have important public health relevance
